Pharmacielo PCLO.V · CAD

Its shares trade on TSX Venture under the ticker PCLO.V. It has been listed since 30 January 2018. In the fiscal year to 31 December 2025, it reported revenue of C$2.5m and a net loss of C$3.6m. At that date it held total assets of C$12.6m and shareholders' equity of −C$11.0m.

PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm produces cannabis oils. The company offers medicinal-grade oil extracts and related products, which provide relief and wellness formulas for patients in need, including those requiring higher levels of tetrahydrocannabinol (THC). The firm's wholly-owned subsidiary is PharmaCielo Colombia Holdings SAS based in Colombia. The firm works together with Cooperativa Caucannabis and more than 60 local regional farmer members in Cauca, Colombia to cultivate cannabis for the production of standardized, medicinal-grade oil extracts and related products. Pharmacielo Ltd holds Colombian licenses for cannabis.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Marc LustigChairman of the Board, Chief Executive Officer, since 2020C$57,500
• Mr. Ian AtacanChief Financial Officer, Director, since 2021C$275,000
• Mr. Andres BoteroChief Operating OfficerC$290,569
• Mr. William PetronLead Independent Director, since 2021C$541,681
• Mr. Douglas BacheIndependent DirectorC$60,000
• Mr. William NicholasIndependent DirectorC$97,132

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.